Methylation of miRNA genes in the pathogenesis of primary kidney and lung tumors
Abstract
MicroRNAs play important role in the protein coding genes expression regulation and are involved in the development of cancer. One of the miRNA gene expression regulation mechanisms is their promoter CpG islands methylation. We investigated CpG-island methylation of eight miRNA genes (MIR-9-1/3, MIR-34b/c, MIR-124a-1/2/3, MIR-129-2) in a representative selected samples of primary kidney and lung tumors (46 cases of each type) using methylation-specific PCR. Methylation of four genes — MIR-124a-1/2/3 and MIR-129-2 in the kidney tumors and MIR-129-2 in lung tumors was studied by us for the first time. It was shown that frequency of methylation of these genes in the studied NSCLC and ccRCC tumor samples was varied from 41% to 67% and was significantly higher than in normal tissue biopsy samples (r < 0.05, Fischer). A significant increase in the frequency of methylation of MIR-124a-3 and MIR-34b/c genes observed in NSCLC was rather different in various histological types — squamous cell carcinoma (SCC) and adenocarcinoma (AC). A significant increase of methylation frequency of MIR-124a-2 and the MIR-129-2 genes was also found in SCC (in difference of AC), which was shown for the first time and can be used in the differential diagnosis of SCC and AK. Correlations of methylation frequencies of several miRNA genes with tumor progression of ccRCC and NSCLC (tumor size, stage, loss of differentiation, metastasis) were revealed here.